What is the catalog number for Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody?

The catalog number for Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody is orb18137.

What sizes are available for Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody?

Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody in stock?

Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Bcl-XS/BCL2L1/XS Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Bcl-2-like protein 1; Bcl2-L-1; Apoptosis regulator Bcl-X; BCL2L1; BCL2L, BCLX

UniProt

Q07817

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence in the middle region of human Bcl-XS, different from the related rat and mouse sequences by one amino acid.

Target

Bcl-2-like protein 1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Metabolism Research

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human

Form

Lyophilized

Molecular Weight

19 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.